113785-82-3

Upstream product

• 128540-55-6 2-acetoxy-4-cyclohexyl-3-(isopropoxycarbonylamino) butyronitrile 
• 143-33-9 sodium cyanide 
• 126832-06-2 N-((R)-2-Cyclohexyl-1-formyl-ethyl)-benzamide 
• 129593-16-4 N-benzoyl-D-cyclohexylalaninol 
• 129593-17-5 Boc-D-cyclohexylalaninol 

Downstream Products

• 115131-72-1 isopropyl (2S,3S)-3-amino-4-cyclohexyl-2-hydroxybutyrate hydrochloride 
• 129704-26-3 isopropyl (2R,3R)-3-amino-4-cyclohexyl-2-hydroxybutyrate hydrochloride 
• 128053-56-5 isopropyl (2R,3R)-3-<-L-histidyl>amino>-4-cyclohexyl-2-hydroxybutyrate 
• 276888-52-9 (2RS,3S)-3-tert-butyloxycarbonylamino-4-cyclohexyl-2-hydroxybutyric acid 
• 128053-57-6 isopropyl (2S,3S)-3-<-L-histidyl>amino>-4-cyclohexyl-2-hydroxybutyrate 
• 140462-45-9 methyl (2R,3S)-2-acetoxy-3-acetylamino-4-cyclohexylbutyrate 
• 140462-46-0 methyl (2S,3S)-2-acetoxy-3-acetylamino-4-cyclohexylbutyrate 
• 126832-10-8 (4S,5S)-4-(cyclohexylmethyl)-5-(isopropoxycarbonyl)-2-oxazolidinone 

Relevant academic research and scientific papers

A Practical Synthesis of threo-3-Amino-2-hydroxycarboxylic Acids

An expeditious synthesis of (2R,3S)-3-amino-4-cyclohexyl-2-hydroxybutyric acid (2) and (2S,3R)-3-amino-2-hydroxy-4-phenylbutyric acid (4), the key components of the renin inhibitor (1) and bestatin (3), respectively, have been accomplished by featuring hi

Orally Potent Human Renin Inhibitors Derived from Angiotensinogen Transition State: Design, Synthesis, and Mode of Interaction

A three-dimensional structure of the complex of human renin and the scissile site P4 Pro to P1' Val of angiotensinogen was deduced in order to design potent human renin inhibitors rationally.On the basis of this structure, an orally

MORPHOLINE CONTAINING AMINO ACID DERIVATIVES

Amino acid derivatives represented by formula STR1 wherein His represents an L-histidyl group, X represents a straight or branched alkoxy group having 1 to 7 carbon atoms, a straight or branched alkylamino group having 1 to 7 carbon atoms, a cycloalkyloxy